InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Shendelman Shoshana, Président et CEO. Officer active across 1 companies, notably Applied Therapeutics Inc.. In total, 8 reports have been published. Total volume traded: €17k. The latest transaction was disclosed on 14 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
0120,900 shares0
Common Stock
SEC:0001209191-22-002970·
0120,900 shares0
Common Stock
SEC:0001209191-22-002966·
0120,900 shares0
Common Stock
SEC:0001209191-22-002970:0·
0120,900 shares0
Common Stock
SEC:0001209191-22-002966:0·
0120,900 shares0
Common Stock
SEC:0001209191-21-070088·
0120,900 shares0
Common Stock
SEC:0001209191-21-070088:0·
€8,718701 shares@ €12.4365100.0% of flow
Common Stock
SEC:0001209191-21-055932·
Ideal exit: 10 Jun 2022 (T+270)
€8,718701 shares@ €12.436550.0% of flow
Common Stock
SEC:0001209191-21-055932:0·
Ideal exit: 10 Jun 2022 (T+270)
8 of 8 declarations
About Shendelman Shoshana
Shendelman Shoshana is the President and CEO of Applied Therapeutics Inc. She leads the company and is responsible for the overall strategy and operational direction. Shoshana plays a key role in product development and market expansion, contributing to Applied Therapeutics' mission of providing innovative solutions in healthcare. Her leadership is essential for the company's success.
